Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, William G. Wierda, Varsha Gandhi et al.|New England Journal of Medicine|2019Cited by 502
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell LymphomaMark W. Clemens, Roberto N. Miranda, L. Jeffrey Medeiros et al.|Journal of Clinical Oncology|2015Cited by 418
Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsAdam S. Sperling, Koichi Takahashi, Veronica Guerra et al.|Blood|2022Cited by 138
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Sa A. Wang, Keyur P. Patel et al.|Leukemia Research|2014Cited by 128
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 InhibitorsAhmad S. Alotaibi, Naval Daver, Musa Yılmaz et al.|Blood Cancer Discovery|2020Cited by 97